| 1922- | JG, | Juglone induces apoptosis of tumor stem-like cells through ROS-p38 pathway in glioblastoma |
| - | in-vitro, | GBM, | U87MG |
| 1921- | JG, | Juglone induces ferroptotic effect on hepatocellular carcinoma and pan-cancer via the FOSL1-HMOX1 axis |
| - | in-vitro, | PC, | NA | - | vitro+vivo, | PC, | NA |
| 1919- | JG, | The Anti-Glioma Effect of Juglone Derivatives through ROS Generation |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | U251 |
| 1917- | JG, | Inhibition of human leukemia cells growth by juglone is mediated via autophagy induction, endogenous ROS production, and inhibition of cell migration and invasion |
| - | in-vitro, | AML, | HL-60 |
| 5118- | JG, | Juglone induces apoptosis and autophagy via modulation of mitogen-activated protein kinase pathways in human hepatocellular carcinoma cells |
| - | in-vitro, | HCC, | HepG2 |
| 5120- | JG, | Juglone can inhibit angiogenesis and metastasis in pancreatic cancer cells by targeting Wnt/β-catenin signaling |
| - | in-vitro, | PC, | NA |
| 5119- | JG, | Juglone Suppresses Inflammation and Oxidative Stress in Colitis Mice |
| - | in-vivo, | Nor, | NA |
| 5113- | JG, | Juglone in Oxidative Stress and Cell Signaling |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 5114- | JG, | Juglone, from Juglans mandshruica Maxim, inhibits growth and induces apoptosis in human leukemia cell HL-60 through a reactive oxygen species-dependent mechanism |
| - | in-vitro, | AML, | HL-60 |
| 5099- | JG, | Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK |
| - | vitro+vivo, | GBM, | LN229 | - | vitro+vivo, | GBM, | T98G |
| 5098- | JG, | Effects of Juglone on Antioxidant Status in Pancreatic Cancer Cell Lines |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | PANC1 |
| 5115- | JG, | Natural Products to Fight Cancer: A Focus on Juglans regia |
| - | Review, | Var, | NA |
| 5116- | JG, | Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells |
| - | in-vitro, | Melanoma, | B16-BL6 |
| 5117- | JG, | https://pubmed.ncbi.nlm.nih.gov/31283929/ |
| - | vitro+vivo, | Liver, | NA |
| 1121- | JG, | Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3β/Snail signaling pathway |
| - | in-vitro, | Pca, | LNCaP |
| 974- | JG, | Juglone down-regulates the Akt-HIF-1α and VEGF signaling pathways and inhibits angiogenesis in MIA Paca-2 pancreatic cancer in vitro |
| - | in-vitro, | PC, | MIA PaCa-2 |
| 4013- | K+, | Apamin Improves Prefrontal Nicotinic Impairment in Mouse Model of Alzheimer's Disease |
| - | in-vitro, | AD, | NA |
| 4014- | K+, | The effects of boiling and leaching on the content of potassium and other minerals in potatoes |
| - | Analysis, | NA, | NA |
| 4005- | K+, | Potassium |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA |
| 4006- | K+, | Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid |
| - | in-vitro, | AD, | NA |
| 4007- | K+, | The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| 4008- | K+, | Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update |
| - | Review, | AD, | NA |
| 4009- | K+, | Na+ and K+ ion imbalances in Alzheimer’s disease |
| - | Human, | AD, | NA |
| 4010- | K+, | Potassium-sparing diuretics might reduce risk of Alzheimer's disease |
| - | Review, | AD, | NA |
| 4012- | K+, | Abnormal potassium-channel function in platelets in Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| 4011- | K+, | Sodium and potassium intakes among US adults: NHANES 2003–2008 |
| - | Analysis, | NA, | NA |
| 2390- | KAE, | Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis |
| - | in-vitro, | CRC, | HCT8 |
| 8085- | KAE, | Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways |
| - | Review, | Var, | NA |
| 8084- | KAE, | Kaempferol treatment ameliorates memory impairments in STZ‑induced neurodegeneration by acting on reelin signaling |
| - | in-vivo, | AD, | NA |
| 8086- | KAE, | Hepatoprotective Effect of Kaempferol: A Review of the Dietary Sources, Bioavailability, Mechanisms of Action, and Safety |
| - | Review, | Nor, | NA |
| 8087- | KAE, | Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways |
| - | Review, | Var, | NA |
| 8088- | KAE, | Kaempferol: Antimicrobial Properties, Sources, Clinical, and Traditional Applications |
| - | Review, | Nor, | NA |
| 8089- | KAE, | Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1 |
| - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Melanoma, | B16-F10 |
| 8090- | KAE, | A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound |
| - | Review, | Nor, | NA |
| 8091- | KAE, | Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT-29 |
| 8092- | KAE, | Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells |
| - | in-vitro, | Colon, | HCT116 | - | in-vitro, | Colon, | DLD1 |
| 8093- | KAE, | Kaempferol inhibits Nrf2 signalling pathway via downregulation of Nrf2 mRNA and induces apoptosis in NSCLC cells |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H460 |
| 8095- | KAE, | Kaempferol: A Key Emphasis to Its Anticancer Potential |
| - | Review, | Var, | NA |
| 8096- | KAE, | 5-FU, | Synergistic effect of kaempferol and 5‑fluorouracil on the growth of colorectal cancer cells by regulating the PI3K/Akt signaling pathway |
| - | in-vitro, | CRC, | HCT8 | - | in-vitro, | CRC, | HCT8 |
| 8097- | KAE, | The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells |
| - | in-vitro, | CRC, | LS174T |
| 8098- | KAE, | Kaempferol induces hepatocellular carcinoma cell death via endoplasmic reticulum stress-CHOP-autophagy signaling pathway |
| - | in-vitro, | HCC, | HepG2 | - | in-vitro, | HCC, | HUH7 |
| 8099- | KAE, | LT, | CHr, | Kaempherol and Luteolin Decrease Claudin-2 Expression Mediated by Inhibition of STAT3 in Lung Adenocarcinoma A549 Cells |
| - | in-vitro, | Lung, | A549 |
| 8100- | KAE, | Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways |
| - | in-vitro, | Cerv, | HeLa |
| 8101- | KAE, | Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway |
| - | vitro+vivo, | ESCC, | KYSE150 | - | vitro+vivo, | ESCC, | Eca109 |
| 8102- | KAE, | Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study |
| - | vitro+vivo, | GC, | MKN-28 | - | vitro+vivo, | GC, | SGC-7901 | - | in-vitro, | GC, | GES-1 |
| 8103- | KAE, | The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions |
| - | in-vitro, | HCC, | HUH7 |
| 8104- | KAE, | A comprehensive and mechanistic review on protective effects of kaempferol against natural and chemical toxins: Role of NF-κB inhibition and Nrf2 activation |
| - | Review, | Nor, | NA |
| 8105- | KAE, | Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review |
| - | Review, | Var, | NA |
| - | in-vitro, | Melanoma, | A375 |
| - | in-vitro, | Ovarian, | A2780S |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid